EBR Systems Inc (EBR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EBR Systems Inc (EBR) has a cash flow conversion efficiency ratio of -0.605x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-15.49 Million ≈ $-10.96 Million USD) by net assets (AU$25.61 Million ≈ $18.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EBR Systems Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how EBR Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EBR Systems Inc total liabilities for a breakdown of total debt and financial obligations.
EBR Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EBR Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Savior Lifetec
TWO:4167
|
-0.026x |
|
Surteco Group SE
XETRA:SUR
|
0.079x |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
0.247x |
|
Genova Property Group AB
ST:GPG
|
0.008x |
|
Barings Participation Investors (the Trust)
NYSE:MPV
|
0.033x |
|
Lealea Enterprise Co Ltd
TW:1444
|
0.003x |
|
MediWound Ltd
F:M8W
|
-0.065x |
|
D&D Platform Reit Co Ltd
KO:377190
|
N/A |
Annual Cash Flow Conversion Efficiency for EBR Systems Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of EBR Systems Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see EBR Systems Inc (EBR) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | AU$25.61 Million ≈ $18.12 Million |
AU$-55.05 Million ≈ $-38.95 Million |
-2.150x | -27.00% |
| 2024-12-31 | AU$24.36 Million ≈ $17.23 Million |
AU$-41.23 Million ≈ $-29.17 Million |
-1.693x | -60.79% |
| 2023-12-31 | AU$31.06 Million ≈ $21.97 Million |
AU$-32.70 Million ≈ $-23.14 Million |
-1.053x | -52.43% |
| 2022-12-31 | AU$43.95 Million ≈ $31.10 Million |
AU$-30.36 Million ≈ $-21.48 Million |
-0.691x | -236579.38% |
| 2021-12-31 | AU$75.90 Million ≈ $53.70 Million |
AU$-22.15K ≈ $-15.67K |
0.000x | -162.62% |
| 2020-12-31 | AU$-37.65 Million ≈ $-26.64 Million |
AU$-17.55K ≈ $-12.42K |
0.000x | -69.40% |
| 2019-12-31 | AU$-13.83 Million ≈ $-9.78 Million |
AU$-21.06K ≈ $-14.90K |
0.002x | -- |
About EBR Systems Inc
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization thera… Read more